QUEST DIAGNOSTICS INC
For the period ended Dec 31, 2024. Filed Feb 20, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 20, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 9B. Other Information
(b) Rule 10b5-1 and Non-Rule 10b5-1 Trading Arrangements by Our Directors and Officers
Our directors and officers (as defined in Rule 16a-1(f) of the Securities Exchange Act of 1934, as amended)adopted, terminated or modified the Rule 10b5-1 trading arrangements (as defined in Item 408 of Regulation S-K) set forth in the table below. No non-Rule 10b5-1 trading arrangements were adopted, modified orterminated by any director or officer during the period covered by this report.
| Name | Title | Type of Trading Arrangement | Security | Action | Date of Action | Duration of Trading Arrangement | Aggregate Number of Securities Covered |
|---|---|---|---|---|---|---|---|
| James E. Davis | Chairman, Chief Executive Officer and President | Rule 10b5-1 plan to sell | Common Stock | Adoption | October 28, 2024 | October 28, 2024 to October 28, 2025* | Up to 56,057* |
| Karthikeyan Kuppusamy | SVP, Clinical Solutions | Rule 10b5-1 plan to sell | Common Stock | Adoption | October 28, 2024 | October 28, 2024 to July 25, 2025* | Up to 2,833* |
- Includes shares of common stock to be released from (a) stock options and/or restricted stock units that are expected to vest and/or (b) performance share awards that may vest, subject to the satisfaction of the applicable performance metrics. The actual number of shares of common stock that will be released is not yet determinable and the actual number of shares of common stock that will be sold will be net of the number of shares withheld to satisfy employee tax withholding obligations.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.